Taxotere recalled by company
due to mislabeling
BRIDGEWATER, NJ --
Mar. 27, 2001 -- Aventis Pharmaceuticals has initiated a voluntary
recall of Taxotere® (docetaxel) for Injection Concentrate
20-mg active and diluent vials.
The recall affected
two production lots that were mistakenly labeled. Cancer doctors
have been notified of the mix-up and an Alert with a copy of
the letter sent to physicians are posted on the FDA's Web site.
The lot numbers for
this recall are: 0P273 (active) which was packaged together with
diluent vials with the following lot numbers: 0T446 (diluent)
or 0T449 (diluent).
There have been no
reports of complaints due to the mislabeled vials.
|